{"data":{"id":"us-ok/okla.-stat.-tit.-63-63-427.2v1","jurisdiction":"us-ok","citation":"Okla. Stat. tit. 63, § 63-427.2v1","heading":"Definitions","body":"As used in the Oklahoma Medical Marijuana and Patient Protection\n\nAct:\n\n1. “Advertising” means the act of providing consideration for\n\nthe publication, dissemination, solicitation, or circulation, of\n\nvisual, oral, or written communication to induce directly or\n\nindirectly any person to patronize a particular medical marijuana\n\nbusiness, or to purchase particular medical marijuana or a medical\n\nmarijuana product. Advertising includes marketing, but does not\n\ninclude packaging and labeling;\n\n2. “Authority” means the Oklahoma Medical Marijuana Authority;\n\n3. “Batch number” means a unique numeric or alphanumeric\n\nidentifier assigned prior to testing to allow for inventory tracking\n\nand traceability;\n\n4. “Cannabinoid” means any of the chemical compounds that are\n\nactive principles of marijuana;\n\n5. “Caregiver” means a family member or assistant who regularly\n\nlooks after a medical marijuana patient license holder whom a\n\nphysician attests needs assistance;\n\n6. “Child-resistant” means special packaging that is:\n\na. designed or constructed to be significantly difficult\n\nfor children under five (5) years of age to open and\n\nnot difficult for normal adults to use properly as\n\ndefined by 16 C.F.R. 1700.15 (1995) and 16 C.F.R.\n\n1700.20 (1995), and\n\nb. resealable to maintain its child-resistant\n\neffectiveness for multiple openings for any product\n\nintended for more than a single use or containing\n\nmultiple servings;\n\n7. “Clone” means a nonflowering plant cut from a mother plant\n\nthat is capable of developing into a new plant and has shown no\n\nsigns of flowering;\n\n8. “Complete application” means a document prepared in\n\naccordance with the provisions set forth in the Oklahoma Medical\n\nMarijuana and Patient Protection Act, rules promulgated pursuant\n\nthereto, and the forms and instructions provided by the Oklahoma\n\nMedical Marijuana Authority including any supporting documentation\n\nrequired and the applicable license application fee;\n\n9. “Director” means the Executive Director of the Oklahoma\n\nMedical Marijuana Authority;\n\n10. “Dispense” means the selling of medical marijuana or a\n\nmedical marijuana product to a qualified patient or the designated\n\ncaregiver of the patient that is packaged in a suitable container\n\nappropriately labeled for subsequent administration to or use by a\n\nqualifying patient;\n\n11. “Dispensary” means a medical marijuana dispensary, an\n\nentity that has been licensed by the Authority pursuant to the\n\nOklahoma Medical Marijuana and Patient Protection Act to purchase\n\nmedical marijuana or medical marijuana products from a licensed\n\nmedical marijuana commercial grower or licensed medical marijuana\n\nprocessor, to prepare and package noninfused pre-rolled medical\n\nmarijuana, and to sell medical marijuana or medical marijuana\n\nproducts to licensed patients and caregivers as defined in this\n\nsection, or sell or transfer products to another licensed\n\ndispensary;\n\n12. “Edible medical marijuana product” means any medical-\n\nmarijuana-infused product for which the intended use is oral\n\nconsumption including, but not limited to, any type of food, drink\n\nor pill;\n\n13. “Entity” means an individual, general partnership, limited\n\npartnership, limited liability company, trust, estate, association,\n\ncorporation, cooperative or any other legal or commercial entity;\n\n14. “Flower” means the reproductive organs of the marijuana or\n\ncannabis plant referred to as the bud or parts of the plant that are\n\nharvested and used for consumption in a variety of medical marijuana\n\nproducts;\n\n15. “Flowering” means the reproductive state of the marijuana\n\nor cannabis plant in which there are physical signs of flower or\n\nbudding out of the nodes of the stem;\n\n16. “Exit package” means an opaque bag that is provided at the\n\npoint of sale in which pre-packaged medical marijuana is placed;\n\n17. “Food-based medical marijuana concentrate” means a medical\nariety of medical marijuana\n\nproducts;\n\n15. “Flowering” means the reproductive state of the marijuana\n\nor cannabis plant in which there are physical signs of flower or\n\nbudding out of the nodes of the stem;\n\n16. “Exit package” means an opaque bag that is provided at the\n\npoint of sale in which pre-packaged medical marijuana is placed;\n\n17. “Food-based medical marijuana concentrate” means a medical\n\nmarijuana concentrate that was produced by extracting cannabinoids\n\nfrom medical marijuana through the use of propylene glycol,\n\nglycerin, butter, olive oil, coconut oil or other typical food-safe\n\ncooking fats;\n\n18. “Harvest batch” means a specifically identified quantity of\n\nmedical marijuana that is uniform in strain, cultivated utilizing\n\nthe same cultivation practices, harvested at the same time from the\n\nsame location and cured under uniform conditions;\n\n19. “Harvested marijuana” means postflowering medical marijuana\n\nnot including trim, concentrate or waste;\n\n20. “Heat- or pressure-based medical marijuana concentrate”\n\nmeans a medical marijuana concentrate that was produced by\n\nextracting cannabinoids from medical marijuana through the use of\n\nheat or pressure;\n\n21. “Immature plant” means a nonflowering marijuana plant that\n\nhas not demonstrated signs of flowering;\n\n22. “Inventory tracking system” means the required tracking\n\nsystem that accounts for the entire life span of medical marijuana\n\nand medical marijuana products including any testing samples thereof\n\nand medical marijuana waste;\n\n23. “Licensed patient” or “patient” means a person who has been\n\nissued a medical marijuana patient license by the Oklahoma Medical\n\nMarijuana Authority;\n\n24. “Licensed premises” means the premises specified in an\n\napplication for a medical marijuana business license, medical\n\nmarijuana research facility license or medical marijuana education\n\nfacility license pursuant to the Oklahoma Medical Marijuana and\n\nPatient Protection Act that are owned or in possession of the\n\nlicensee and within which the licensee is authorized to cultivate,\n\nmanufacture, distribute, sell, store, transport, test or research\n\nmedical marijuana or medical marijuana products in accordance with\n\nthe provisions of the Oklahoma Medical Marijuana and Patient\n\nProtection Act and rules promulgated pursuant thereto;\n\n25. “Manufacture” means the production, propagation,\n\ncompounding or processing of a medical marijuana product, excluding\n\nmarijuana plants, either directly or indirectly by extraction from\n\nsubstances of natural or synthetic origin, or independently by means\n\nof chemical synthesis, or by a combination of extraction and\n\nchemical synthesis;\n\n26. “Marijuana” shall have the same meaning as such term is\n\ndefined in Section 2-101 of this title and shall not include any\n\nplant or material containing delta-8 or delta 10\n\ntetrahydrocannabinol which is grown, processed, or sold pursuant to\n\nthe provisions of the Oklahoma Industrial Hemp Program;\n\n27. “Material change” means any change that would affect the\n\nqualifications for licensure of an applicant or licensee;\n\n28. “Mature plant” means a harvestable female marijuana plant\n\nthat is flowering;\n\n29. “Medical marijuana business (MMB)” means a licensed medical\n\nmarijuana dispensary, medical marijuana processor, medical marijuana\n\ncommercial grower, medical marijuana laboratory, medical marijuana\n\nbusiness operator or a medical marijuana transporter;\n\n30. “Medical marijuana concentrate” or “concentrate” means a\n\nspecific subset of medical marijuana that was produced by extracting\n\ncannabinoids from medical marijuana. Categories of medical\n\nmarijuana concentrate include water-based medical marijuana\n\nconcentrate, food-based medical marijuana concentrate, solvent-based\n\nmedical marijuana concentrate, and heat- or pressure-based medical\n\nmarijuana concentrate;\n\nf medical marijuana that was produced by extracting\n\ncannabinoids from medical marijuana. Categories of medical\n\nmarijuana concentrate include water-based medical marijuana\n\nconcentrate, food-based medical marijuana concentrate, solvent-based\n\nmedical marijuana concentrate, and heat- or pressure-based medical\n\nmarijuana concentrate;\n\n31. “Medical marijuana commercial grower” or “commercial\n\ngrower” means an entity licensed to cultivate, prepare and package\n\nmedical marijuana or package medical marijuana as pre-rolls, and\n\ntransfer or contract for transfer medical marijuana and medical\n\nmarijuana pre-rolls to a medical marijuana dispensary, medical\n\nmarijuana processor, any other medical marijuana commercial grower,\n\nmedical marijuana research facility or medical marijuana education\n\nfacility. A commercial grower may sell seeds, flower or clones to\n\ncommercial growers pursuant to the Oklahoma Medical Marijuana and\n\nPatient Protection Act;\n\n32. “Medical marijuana education facility” or “education\n\nfacility” means a person or entity approved pursuant to the Oklahoma\n\nMedical Marijuana and Patient Protection Act to operate a facility\n\nproviding training and education to individuals involving the\n\ncultivation, growing, harvesting, curing, preparing, packaging or\n\ntesting of medical marijuana, or the production, manufacture,\n\nextraction, processing, packaging or creation of medical-marijuana-\n\ninfused products or medical marijuana products as described in the\n\nOklahoma Medical Marijuana and Patient Protection Act;\n\n33. “Medical-marijuana-infused product” means a product infused\n\nwith medical marijuana including, but not limited to, edible\n\nproducts, ointments and tinctures;\n\n34. “Medical marijuana product” or “product” means a product\n\nthat contains cannabinoids that have been extracted from plant\n\nmaterial or the resin therefrom by physical or chemical means and is\n\nintended for administration to a qualified patient including, but\n\nnot limited to, oils, tinctures, edibles, pills, topical forms,\n\ngels, creams, vapors, patches, liquids, and forms administered by a\n\nnebulizer, excluding live plant forms which are considered medical\n\nmarijuana;\n\n35. “Medical marijuana processor” means a person or entity\n\nlicensed pursuant to the Oklahoma Medical Marijuana and Patient\n\nProtection Act to operate a business including the production,\n\nmanufacture, extraction, processing, packaging or creation of\n\nconcentrate, medical-marijuana-infused products or medical marijuana\n\nproducts as described in the Oklahoma Medical Marijuana and Patient\n\nProtection Act;\n\n36. “Medical marijuana research facility” or “research\n\nfacility” means a person or entity approved pursuant to the Oklahoma\n\nMedical Marijuana and Patient Protection Act to conduct medical\n\nmarijuana research. A medical marijuana research facility is not a\n\nmedical marijuana business;\n\n37. “Medical marijuana testing laboratory” or “laboratory”\n\nmeans a public or private laboratory licensed pursuant to the\n\nOklahoma Medical Marijuana and Patient Protection Act to conduct\n\ntesting and research on medical marijuana and medical marijuana\n\nproducts;\n\n38. “Medical marijuana transporter” or “transporter” means a\n\nperson or entity that is licensed pursuant to the Oklahoma Medical\n\nMarijuana and Patient Protection Act. A medical marijuana\n\ntransporter does not include a medical marijuana business that\n\ntransports its own medical marijuana, medical marijuana concentrate\n\nor medical marijuana products to a property or facility adjacent to\n\nor connected to the licensed premises if the property is another\n\nlicensed premises of the same medical marijuana business;\n\n39. “Medical marijuana waste” or “waste” means unused, surplus,\n\nreturned or out-of-date marijuana, plant debris of the plant of the\n\ngenus Cannabis including dead plants and all unused plant parts,\nntrate\n\nor medical marijuana products to a property or facility adjacent to\n\nor connected to the licensed premises if the property is another\n\nlicensed premises of the same medical marijuana business;\n\n39. “Medical marijuana waste” or “waste” means unused, surplus,\n\nreturned or out-of-date marijuana, plant debris of the plant of the\n\ngenus Cannabis including dead plants and all unused plant parts,\n\nexcept the term shall not include roots, stems, stalks and fan\n\nleaves;\n\n40. “Medical use” means the acquisition, possession, use,\n\ndelivery, transfer or transportation of medical marijuana, medical\n\nmarijuana products, medical marijuana devices or paraphernalia\n\nrelating to the administration of medical marijuana to treat a\n\nlicensed patient;\n\n41. “Mother plant” means a marijuana plant that is grown or\n\nmaintained for the purpose of generating clones, and that will not\n\nbe used to produce plant material for sale to a medical marijuana\n\nprocessor or medical marijuana dispensary;\n\n42. “Oklahoma physician” or “physician” means a physician\n\nlicensed by and in good standing with the State Board of Medical\n\nLicensure and Supervision, the State Board of Osteopathic Examiners\n\nor the Board of Podiatric Medical Examiners;\n\n43. “Oklahoma resident” means an individual who can provide\n\nproof of residency as required by the Oklahoma Medical Marijuana and\n\nPatient Protection Act;\n\n44. “Owner” means, except where the context otherwise requires,\n\na direct beneficial owner including, but not limited to, all persons\n\nor entities as follows:\n\na. all shareholders owning an interest of a corporate\n\nentity and all officers of a corporate entity,\n\nb. all partners of a general partnership,\n\nc. all general partners and all limited partners that own\n\nan interest in a limited partnership,\n\nd. all members that own an interest in a limited\n\nliability company,\n\ne. all beneficiaries that hold a beneficial interest in a\n\ntrust and all trustees of a trust,\n\nf. all persons or entities that own interest in a joint\n\nventure,\n\ng. all persons or entities that own an interest in an\n\nassociation,\n\nh. the owners of any other type of legal entity, and\n\ni. any other person holding an interest or convertible\n\nnote in any entity which owns, operates or manages a\n\nlicensed facility;\n\n45. “Package” or “packaging” means any container or wrapper\n\nthat may be used by a medical marijuana business to enclose or\n\ncontain medical marijuana;\n\n46. “Person” means a natural person, partnership, association,\n\nbusiness trust, company, corporation, estate, limited liability\n\ncompany, trust or any other legal entity or organization, or a\n\nmanager, agent, owner, director, servant, officer or employee\n\nthereof, except that person does not include any governmental\n\norganization;\n\n47. “Pesticide” means any substance or mixture of substances\n\nintended for preventing, destroying, repelling or mitigating any\n\npest or any substance or mixture of substances intended for use as a\n\nplant regulator, defoliant or desiccant, except that the term\n\npesticide shall not include any article that is a “new animal drug”\n\nas designated by the United States Food and Drug Administration;\n\n48. “Production batch” means:\n\na. any amount of medical marijuana concentrate of the\n\nsame category and produced using the same extraction\n\nmethods, standard operating procedures and an\n\nidentical group of harvest batch of medical marijuana,\n\nor\n\nb. any amount of medical marijuana product of the same\n\nexact type, produced using the same ingredients,\n\nstandard operating procedures and the same production\n\nbatch of medical marijuana concentrate;\n\n49. “Public institution” means any entity established or\n\ncontrolled by the federal government, state government, or a local\n\ngovernment or municipality including, but not limited to,\n\ninstitutions of higher education or related research institutions;\n\n50. “Public money” means any funds or money obtained by the\noperating procedures and the same production\n\nbatch of medical marijuana concentrate;\n\n49. “Public institution” means any entity established or\n\ncontrolled by the federal government, state government, or a local\n\ngovernment or municipality including, but not limited to,\n\ninstitutions of higher education or related research institutions;\n\n50. “Public money” means any funds or money obtained by the\n\nholder from any governmental entity including, but not limited to,\n\nresearch grants;\n\n51. “Recommendation” means a document that is signed or\n\nelectronically submitted by a physician on behalf of a patient for\n\nthe use of medical marijuana pursuant to the Oklahoma Medical\n\nMarijuana and Patient Protection Act;\n\n52. “Registered to conduct business” means a person that has\n\nprovided proof that the business applicant or licensee is in good\n\nstanding with the Secretary of State;\n\n53. “Remediation” means the process by which a harvest batch or\n\nproduction batch that fails testing undergoes a procedure to remedy\n\nthe harvest batch or production batch and is retested in accordance\n\nwith state laws, rules and regulations;\n\n54. “Research project” means a discrete scientific endeavor to\n\nanswer a research question or a set of research questions related to\n\nmedical marijuana and is required for a medical marijuana research\n\nlicense. A research project shall include a description of a\n\ndefined protocol, clearly articulated goals, defined methods and\n\noutputs, and a defined start and end date. The description shall\n\ndemonstrate that the research project will comply with all\n\nrequirements in the Oklahoma Medical Marijuana and Patient\n\nProtection Act and rules promulgated pursuant thereto. All research\n\nand development conducted by a medical marijuana research facility\n\nshall be conducted in furtherance of an approved research project;\n\n55. “Revocation” means the final decision by the Authority that\n\nany license issued pursuant to the Oklahoma Medical Marijuana and\n\nPatient Protection Act is rescinded because the individual or entity\n\ndoes not comply with the applicable requirements set forth in the\n\nOklahoma Medical Marijuana and Patient Protection Act or rules\n\npromulgated pursuant thereto;\n\n56. “School” means a public or private elementary, middle or\n\nhigh school, or technology center school which is primarily used for\n\nclassroom instruction. A homeschool, daycare or child-care facility\n\nshall not be considered a school as used in the Oklahoma Medical\n\nMarijuana and Patient Protection Act;\n\n57. “Shipping container” means a hard-sided container with a\n\nlid or other enclosure that can be secured in place. A shipping\n\ncontainer is used solely for the transport of medical marijuana,\n\nmedical marijuana concentrate, or medical marijuana products between\n\nmedical marijuana businesses, a medical marijuana research facility,\n\nor a medical marijuana education facility;\n\n58. “Solvent-based medical marijuana concentrate” means a\n\nmedical marijuana concentrate that was produced by extracting\n\ncannabinoids from medical marijuana through the use of a solvent\n\napproved by the Executive Director;\n\n59. “State Question” means Oklahoma State Question No. 788,\n\nInitiative Petition No. 412, approved by a majority vote of the\n\ncitizens of Oklahoma on June 26, 2018;\n\n60. “Strain” means the name given to a particular variety of\n\nmedical marijuana that is based on a combination of factors which\n\nmay include, but is not limited to, botanical lineage, appearance,\n\nchemical profile and accompanying effects. An example of a “strain”\n\nwould be “OG Kush” or “Pineapple Express”;\n\n61. “THC” means tetrahydrocannabinol, which is the primary\n\npsychotropic cannabinoid in marijuana formed by decarboxylation of\n\nnaturally tetrahydrocannabinolic acid, which generally occurs by\n\nexposure to heat;\n\n62. “Transporter agent” means a person who transports medical\nappearance,\n\nchemical profile and accompanying effects. An example of a “strain”\n\nwould be “OG Kush” or “Pineapple Express”;\n\n61. “THC” means tetrahydrocannabinol, which is the primary\n\npsychotropic cannabinoid in marijuana formed by decarboxylation of\n\nnaturally tetrahydrocannabinolic acid, which generally occurs by\n\nexposure to heat;\n\n62. “Transporter agent” means a person who transports medical\n\nmarijuana or medical marijuana products as an employee of a licensed\n\nmedical marijuana business and holds a transporter agent license\n\nspecific to that business pursuant to the Oklahoma Medical Marijuana\n\nand Patient Protection Act;\n\n63. “Universal symbol” means the image established by the\n\nOklahoma Medical Marijuana Authority and made available to licensees\n\nthrough its website indicating that the medical marijuana or the\n\nmedical marijuana product contains THC;\n\n64. “Usable marijuana” means the dried leaves, flowers, oils,\n\nvapors, waxes and other portions of the marijuana plant and any\n\nmixture or preparation thereof, excluding seeds, roots, stems,\n\nstalks and fan leaves; and\n\n65. “Water-based medical marijuana concentrate” means a\n\nconcentrate that was produced by extracting cannabinoids from\n\nmedical marijuana through the use of only water, ice or dry ice.","path":["OK Code","Title 63"],"source_url":"https://www.oklegislature.gov/OK_Statutes/CompleteTitles/os63.pdf","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:36Z","sha256":"53574ee9bf8e2ee03c533c026df223aa7c1dd7ac0911e1c21678a23f4f1567b6","source_id":"us-ok","stale":false,"prev":"us-ok/okla.-stat.-tit.-63-63-427.29","next":"us-ok/okla.-stat.-tit.-63-63-427.2v2"},"notice":"GroundRules: Original legal text. Not legal advice."}